After the malignant spread of rectal cancer patients, they can be timely treated by surgical resection, radiotherapy, targeted therapy, immunotherapy and other methods.
Rectal cancer is a common malignant tumor, which can be caused by various factors such as bad dietary habits and heredity. With the development of the disease, malignant spread may occur. At this time, if there is a chance of surgery and the patient can tolerate surgery, surgical resection is feasible, and radiotherapy can be supplemented according to the condition of the patient after surgery.
In addition, tumor cells can be killed by the energy released by high-energy rays, i.e. radiotherapy, which is often combined with chemotherapy. Commonly used chemotherapy drugs include fluorouracil, oxaliplatin and so on.
Targeted therapy can precisely kill tumor cells, commonly used drugs such as bevacizumab and cetuximab.
Immunotherapy is also commonly used in rectal cancer treatment, commonly used drugs such as Navulizumab. Note that all the above drugs should be applied under the guidance of doctors.
If the patient’s general condition is poor and cannot tolerate anti-tumor treatment, symptomatic supportive treatment can be given. It is suggested that patients should carry out standardized treatment under the guidance of professional doctors.